Indication
Primary Breast Cancer AR+ve TNBN
1 clinical trial
1 product
1 drug
Clinical trial
Phase II Window of Opportunity Study of Short-term Preoperative Treatment With Enzalutamide (Alone or in Combination With Exemestane) in Patients With Primary Breast CancerStatus: Completed, Estimated PCD: 2016-12-31
Drug
enzalutamideProduct
Exemestane